150 related articles for article (PubMed ID: 19727206)
1. Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.
Kobayashi K; Ogasawara M; Kiyama Y; Miyazono T; Kagawa K; Imai K; Hirano T; Kobayashi N; Tanimoto M; Kasai M
Acta Med Okayama; 2009 Aug; 63(4):213-6. PubMed ID: 19727206
[TBL] [Abstract][Full Text] [Related]
2. Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Beiras-Fernandez A; Bigdeli AK; Nickel T; Michel S; Ueberfuhr P; Reichart B; Kaczmarek I
Exp Clin Transplant; 2011 Aug; 9(4):279-83. PubMed ID: 21819376
[TBL] [Abstract][Full Text] [Related]
3. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
Ader F; Bienvenu AL; Rammaert B; Nseir S
Int J Chron Obstruct Pulmon Dis; 2009; 4():279-87. PubMed ID: 19684861
[TBL] [Abstract][Full Text] [Related]
4. Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
Mucha K; Foroncewicz B; Orłowski T; Religioni J; Bobek-Billewicz B; Jarząb B; Raczyńska J; Krawczyk M; Pączek L
Ann Transplant; 2013 May; 18():238-42. PubMed ID: 23792526
[TBL] [Abstract][Full Text] [Related]
5. Our 2015 approach to invasive pulmonary aspergillosis.
Liss B; Vehreschild JJ; Bangard C; Maintz D; Frank K; Grönke S; Michels G; Hamprecht A; Wisplinghoff H; Markiefka B; Hekmat K; Vehreschild MJ; Cornely OA
Mycoses; 2015 Jun; 58(6):375-82. PubMed ID: 25808916
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Ouchi H; Fujita M; Ikegame S; Inoshima I; Harada E; Nakanishi Y
J Infect Chemother; 2007 Aug; 13(4):258-62. PubMed ID: 17721689
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
8. [Invasive aspergillosis: new tools for a targeted medical management].
Wintenberger C
Med Mal Infect; 2011 Dec; 41(12):679-83. PubMed ID: 22137038
[No Abstract] [Full Text] [Related]
9. Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Yu J; Mu X; Li R
J Clin Microbiol; 2013 Apr; 51(4):1327-9. PubMed ID: 23363828
[TBL] [Abstract][Full Text] [Related]
10. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
[TBL] [Abstract][Full Text] [Related]
11. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
Azzola A; Passweg JR; Habicht JM; Bubendorf L; Tamm M; Gratwohl A; Eich G
J Clin Microbiol; 2004 Oct; 42(10):4805-8. PubMed ID: 15472346
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
Sandherr M; Maschmeyer G
Eur J Med Res; 2011 Apr; 16(4):139-44. PubMed ID: 21486727
[TBL] [Abstract][Full Text] [Related]
13. Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
Mosquera RA; Estrada L; Clements RM; Jon CK
BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24248318
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
Xu XY; Sun HM; Zhao BL; Shi Y
J Mycol Med; 2013 Mar; 23(1):64-9. PubMed ID: 23375859
[TBL] [Abstract][Full Text] [Related]
15. Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.
Wu Z; Ling Z; Shao F; Sheng J; Li L
J Int Med Res; 2012; 40(5):1958-65. PubMed ID: 23206479
[TBL] [Abstract][Full Text] [Related]
16. [Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Shindo M; Sato K; Jimbo J; Hosoki T; Ikuta K; Sano A; Nishimura K; Torimoto Y; Kohgo Y
Rinsho Ketsueki; 2007 May; 48(5):412-7. PubMed ID: 17571588
[TBL] [Abstract][Full Text] [Related]
17. [The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Sav H; Atalay MA; Unal E; Koç N
Mikrobiyol Bul; 2012 Oct; 46(4):695-701. PubMed ID: 23188584
[TBL] [Abstract][Full Text] [Related]
18. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
[TBL] [Abstract][Full Text] [Related]
19. Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
Wu CJ; Lee HC; Lo HJ; Ko WC
Diagn Microbiol Infect Dis; 2011 Aug; 70(4):528-30. PubMed ID: 21658879
[TBL] [Abstract][Full Text] [Related]
20. [Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
Knüttgen D; Kamp M; Ströhlein M; Matten J; Chemaissani A; Ernestus K; Sakka SG; Wappler F
Anaesthesist; 2009 Mar; 58(3):262-7. PubMed ID: 19247622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
